Children's hospital association consensus statements for comorbidities of childhood obesity

Childhood Obesity

Volumn 10, Issue 4, 2014, Pages 304-317

  Estrada, Elizabeth ^a,j   Eneli, Ihuoma ^b   Hampl, Sarah ^c   Mietus Snyder, Michele ^d   Mirza, Nazrat ^d   Rhodes, Erinn ^e   Sweeney, Brooke ^f   Tinajero Deck, Lydia ^g   Woolford, Susan J ^h   Pont, Stephen J ⁱ  

^a UNIVERSITY OF CONNECTICUT   (United States)

^b OHIO STATE UNIVERSITY   (United States)

^c UNIVERSITY OF MISSOURI KANSAS CITY   (United States)

^d GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

^e BOSTON CHILDREN S HOSPITAL   (United States)

^f University of Louisville School of Medicine   (United States)

^g CHILDREN S HOSPITAL OAKLAND   (United States)

^h UNIVERSITY OF MICHIGAN   (United States)

ⁱ UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^j UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

CHILD; COMORBIDITY; COMPLICATION; CONSENSUS; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HUMAN; HYPERTENSION; INFANT; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; PEDIATRIC OBESITY; POLYCYSTIC OVARY SYNDROME; PRACTICE GUIDELINE; PRESCHOOL CHILD; SLEEP APNEA SYNDROMES; UNITED STATES;

CHILD; CHILD, PRESCHOOL; COMORBIDITY; CONSENSUS; DIABETES MELLITUS, TYPE 2; DYSLIPIDEMIAS; FEMALE; HUMANS; HYPERTENSION; INFANT; MALE; NON-ALCOHOLIC FATTY LIVER DISEASE; PEDIATRIC OBESITY; POLYCYSTIC OVARY SYNDROME; SLEEP APNEA SYNDROMES; UNITED STATES;

EID: 84905497972     PISSN: 21532168     EISSN: 21532176     Source Type: Journal    
DOI: 10.1089/chi.2013.0120     Document Type: Article

References (50)

1. Odgen C, Carroll M. Prevalence of obesity among children and adolescents: United States, trends 1963-1965 through 2007-2008. CDC, National Center for Health Statistics: Atlanta, GA, 2010.
2. Rubin CM. Management of pediatric overweight/obesity: A survey of primary care providers. Is it time for a clinical alternative? Child Obes 2011;7:400-408.
3. Zamosky L. The obesity epidemic. While America swallows $147 billion in obesity-related healthcare costs, physicians called on to confront the crisis. Med Econ 2013;90:14-17.
4. Mazur A, Matusik P, Revert K, et al. Childhood obesity: Knowledge, attitudes, and practices of European pediatric care providers. Pediatrics 2013;132:e100-e108.
5. Walsh CO, Milliren CE, Feldman HA, et al. Factors affecting subspecialty referrals by pediatric primary care providers for children with obesity-related comorbidities. Clin Pediatr (Phila) 2013;52:777-785.
6. National Association of Children's Hospitals and Related Institutions (NACHRI). Pediatric subspecialist physician shortages affect access to care. 2009. Available at www.childrenshospitals.net/Content/ContentFolders34/ BenchmarkingData/AnnualSurvey/pediatric-subspecialty-poster.pdf Last accessed November 15, 2013.
7. Jelalian E, Boergers J, Alday CS, et al. Survey of physician attitudes and practices related to pediatric obesity. Clin Pediatr (Phila) 2003;42:235-245.
8. Ogden CL, Carroll MD, Kit BK, et al. Prevalence of childhood and adult obesity in the United States, 2011-2012. JAMA 2014;311: 806-814.
9. National High Blood Pressure Education Program Working Group on High Blood Pressure in Children and Adolescents. The fourth report on the diagnosis, evaluation, and treatment of high blood pressure in children and adolescents. Pediatrics 2004;114(2 Suppl 4th Report):555-576.
10. National Institutes of Health (NIH). Lipids and lipoproteins. In: Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents. NIH Publication No. 12-7486. National Institutes of Health: Bethesda, MD, 2012.
11. Barlow SE; Expert Committee. Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: Summary report. Pediatrics 2007;120(Suppl. 4):S164-S192.
12. Kapadia C, Zeitler P.; and Drugs and Therapeutics Committee of the Pediatric Endocrine Society. Hemoglobin A1c measurement for the diagnosis of Type 2 diabetes in children. Int J Pediatr Endocrinol 2012;2012:31.
13. Expert Panel on Integrated Guidelines for Cardiovascular Health and Risk Reduction in Children and Adolescents; National Heart, Lung, and Blood Institute. Expert panel on integrated guidelines for cardiovascular health and risk reduction in children and adolescents: Summary report. Pediatrics 2011;128(Suppl. 5):S213-S256.
14. Azziz R, Carmina E, Dewailly D, et al. Positions statement: Criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: An Androgen Excess Society guideline. J Clin Endocrinol Metab 2006;91:4237-4245.
15. Moran L, Pasquali R, Teede H, et al. Treatment of obesity in polycystic ovary syndrome: A position statement of the Androgen Excess and Polycystic Ovary Syndrome Society. Fertil Steril 2009;92:1966-1982.
16. American Association of Clinical Endocrinologists Polycystic Ovary Syndrome Writing Committee. American Association of Clinical Endocrinologists Position Statement on Metabolic and Cardiovascular Consequences of Polycystic Ovary Syndrome. Endocr Pract 2005;11:126-134.
17. Wild R, Carmina E, Diamanti-Kandarakis E, et al. Assessment of cardiovascular risk and prevention of cardiovascular disease in women with the polycystic ovary syndrome: A consensus statement by the Androgen Excess and Polycystic Ovary Syndrome (AE-PCOS) Society. J Clin Endocrinol Metab 2010;95:2038-2049.
18. Levy-Marchal C, Arslanian S, Cutfield W, et al. Insulin resistance in children: Consensus, perspective, and future directions. J Clin Endocrinol Metab 2010;95:5189-5198.
19. Ross AC, Manson JE, Abrams SA, et al. The 2011 dietary reference intakes for calcium and vitamin D: What dietetics practitioners need to know. J Am Diet Assoc 2011;111:524-527.
20. Lee JM, Wu EL, Tarini B, et al. Diagnosis of diabetes using hemoglobin A1c: Should recommendations in adults be extrapolated to adolescents? J Pediatr 2011;158:947-952.e1-e3.
21. American Diabetes Association. Standards of medical care in diabetes-2010. Diabetes Care 2010;33(Suppl. 1):S11-S61.
22. Alberti KG, Zimmet PZ. Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: Diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med 1998;15:539-553.
23. American Diabetes Association. Diagnosis and classification of diabetes mellitus. Diabetes Care 2013;36(Suppl. 1):S67-S74.
24. Cook S, Kavey R. Dyslipidemia and pediatric obesity. Pediatric Clinics N Am 2011;58:1363-1373.
25. Kavey RE, Mietus-Snyder M. Beyond cholesterol: The atherogenic consequences of combined dyslipidemia. J Pediatr 2012;161:977-979.
26. Daniels S, Greer F. Lipid screening and cardiovascular health in childhood. Pediatrics 2008;122:198-208.
27. Garaiova I, Muchova J, Nagyova Z, et al. Effect of a plant sterol, fish oil and B vitamin combination on cardiovascular risk factors in hypercholesterolemic children and adolescents: A pilot study. Nutr J 2013;12:7.
28. Mantyselka P, Niskanen L, Kautiainen H, et al. Cross-sectional and longitudinal associations of circulating omega-3 and omega-6 fatty acids with lipoprotein particle concentrations and sizes: Population-based cohort study with 6-year follow-up. Lipids Health Dis 2014;13:28.
29. Engler MM, Engler MB, Malloy MJ, et al. Effect of docosahexaenoic acid on lipoprotein subclasses in hyperlipidemic children (the EARLY study). Am J Cardiol 2005;95:869-871.
30. Armstrong GT, Liu Q, Yasui Y, et al. Late mortality among 5-year survivors of childhood cancer: A summary from the Childhood Cancer Survivor Study. J Clin Oncol 2009;27:2328-2338.
31. Dengel DR, Kelly AS, Zhang L, et al. Signs of early sub-clinical atherosclerosis in childhood cancer survivors. Pediatr Blood Cancer 2014;61:532-537.
32. Mencin A, Lavine J. Nonalcoholic fatty liver disease in children. Curr Opin Clin Nutr Metab Care 2011;14:151-157.
33. Mencin AA, Lavine JE. Advances in pediatric nonalcoholic fatty liver disease. Pediatr Clin North Am 2011;58:1375-1392.
34. Schwimmer JB, Pardee PE, Lavine JE, et al. Cardiovascular risk factors and the metabolic syndrome in pediatric nonalcoholic fatty liver disease. Circulation 2008;118:277-283.
35. Bremer A, Mietus-Snyder M, Lustig R. Toward a unifying hypothesis of metabolic syndrome. Pediatrics 2012;129:557-570.
36. Schwimmer JB, Dunn W, Norman GJ, et al. SAFETY study: Alanine aminotransferase cutoff values are set too high for reliable detection of pediatric chronic liver disease. Gastroenterology 2010;138:1357-1364.
37. Freedman D, Khan L, Dietz W, et al. Relationship of childhood obesity to coronary heart disease risk factors in adulthood: The Bogalusa Heart Study. Pediatrics 2001;108:712-718.
38. Franks S. Polycystic ovary syndrome. N Engl J Med 1995;333: 853-861.
39. Franks S. Polycystic ovary syndrome in adolescents. Int J Obes (Lond) 2008;32:1035-1041.
40. Azziz R, Woods K, Reyna R, et al. The prevalence and features of the polycystic ovary syndrome in an unselected population. J Clin Endocrinol Metab 2004;89:2745-2749.
41. Ehrmann D. Polycystic ovary syndrome. N Engl J Med 2005;352: 1223-1236.
42. Zawadski J, Dunaif A. Diagnostic criteria for polycystic ovary syndrome: Towards a rational approach. In: Dunaif A, Givens J, Haseltine F (eds), Polycystic Ovary Syndrome. Blackwell Scientific: Boston, MA, 1992, pp. 377-384.
43. Rotterdam ESHRE/ASRM-Sponsored PCOS consensus workshop group. Revised 2003 consensus on diagnostic criteria and longterm health risks related to polycystic ovary syndrome (PCOS). Hum Reprod 2004;19:41-47.
44. Krebs N, Himes J, Jacobson D, et al. Assessment of child and adolescent overweight and obesity. Pediatrics 2007;120:s193-s228.
45. Diaz A, Laufer M, Breech L. Menstruation in girls and adolescents: Using the menstrual cycle as a vital sign. Pediatrics 2006; 118:2245-2250.
46. Salley K, Wickham E, Cheang K, et al. Glucose intolerance in polycystic ovary syndrome: A position statement of the Androgen Excess Society. J Clin Endocrinol Metab 2007;92: 4546-4556.
47. Palmert M, Gordon C, Kartashov A, et al. Screening for abnormal glucose tolerance in adolescents with polycystic ovary syndrome. J Clin Endocrinol Metab 2002;87:1017-1023.
48. Warren-Ulanch J, Arslanian S. Treatment of PCOS in adolescence. Best Pract Res Clin Endocrinol Metab 2006;20:311-330.
49. Hoeger K. Role of lifestyle modification in the management of polycystic ovary syndrome. Best Pract Res Clin Endocrinol Metab 2006;20:293-310.
50. Escobar-Morreale H, Carmina E, Dewailly D, et al. Epidemiology, diagnosis and management of hirsutism: A consensus statement by the Androgen Excess and Polycystic Ovary Syndrome Society. Hum Reprod Update 2012;18:146-170.